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Abstract: Cancer is one of the leading causes of death worldwide and early detection provides 
the best possible prognosis for cancer patients. Nanotechnology is the branch of engineering 
that deals with the manipulation of individual atoms and molecules. This area of science has 
the potential to help identify cancerous cells and to destroy them by various methods such 
as drug delivery or thermal treatment of cancer. Carbon nanotubes (CNT) and quantum dots 
(QDs) are the two nanoparticles, which have received considerable interest in view of their 
application for diagnosis and treatment of cancer. Fluorescent nanoparticles known as QDs are 
gaining momentum as imaging molecules with life science and clinical applications. Clinically 
they can be used for localization of cancer cells due to their nano size and ability to penetrate 
individual cancer cells and high-resolution imaging derived from their narrow emission bands 
compared with organic dyes. CNTs are of interest to the medical community due to their unique 
properties such as the ability to deliver drugs to a site of action or convert optical energy into 
thermal energy. By attaching antibodies that bind specifically to tumor cells, CNTs can navigate 
to malignant tumors. Once at the tumor site, the CNTs enter into the cancer cells by penetration 
or endocytosis, allowing drug release, and resulting in specific cancer cell death. Alternatively, 
CNTs can be exposed to near-infrared light in order to thermally destroy the cancer cells. The 
amphiphilic nature of CNTs allows them to penetrate the cell membrane and their large surface 
area (in the order of 2600 m2/g) allows drugs to be loaded into the tube and released once inside 
the cancer cell. Many research laboratories, including our own, are investigating the conjugation 
of QDs to CNTs to allow localization of the cancer cells in the patient, by imaging with QDs, 
and subsequent cell killing, via drug release or thermal treatment. This is an area of huge interest 
and future research and therapy will focus on the multimodality of nanoparticles. In this review, 
we seek to explore the biomedical applications of QDs conjugated to CNTs, with a particular 
emphasis on their use as therapeutic platforms in oncology.
Keywords: carbon nanotubes, quantum dots, cancer, photothermal therapy, drug delivery, 
cytotoxicity, near-infrared light
Introduction
The diagnosis and treatment of cancer remains a key challenge for biomedical technology. 
While many classes of anticancer drugs have been discovered and have found widespread 
use, the majority of conventional chemotherapy treatments are associated with side 
effects that may include hair loss, nausea, or myocardial infarction.1 In addition, there 
may be an increased risk of infertility, neurotoxicity, nephrotoxicity, vascular toxicity, 
and thromboembolic complications.2 Alongside these issues, other problems associated 
with conventional chemotherapy include difficulties in clinical administration of 
drugs, multidrug-resistant tumors, and the inability of the drugs to access the specific 
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tumor site.2,3 Due to the above issues, much research has 
focused on different approaches toward targeting cancer with 
drugs that show maximum treatment efficiency with minimum 
side effects in vivo.3 Important factors influencing the design 
of targeted drug-delivery systems include an efficient means 
of delivery, preservation of drug–molecular bioactivity, and 
the enhancement of drug loading and release kinetics toward 
the drug targets.4 Nanomaterials have shown potential in 
biomedical applications and have received considerable interest 
in recent years, especially with respect to their future application 
in the field of cancer diagnosis and cancer treatment.5 One of the 
main factors which make nanoparticles particularly interesting 
to biomedical science is the size of the materials. This allows 
them to escape through leaky tumor blood vessels; a feature that 
results in their accumulation in the parenchyma surrounding 
tumor blood vessels following systemic injection.6 The fast-
growing field of nanotechnology has given rise to the design of 
new nanomaterials that may circumvent some issues that have 
been highlighted previously with regard to biocompatibility, 
and these materials may be used in cancer-related applications. 
Among the new materials to emerge are carbon nanotubes 
(CNTs) and quantum dots (QDs), both of which have been 
the subject of intense investigation with promising results 
from different in vitro and in vivo approaches for the study of 
cancer cell metastasis.7,8
CNTs are well-ordered, all carbon, hollow graphitic 
nanomaterials with a high aspect ratio, high surface area and 
ultralight weight, in addition they contain unique physical and 
chemical properties.4,5 CNTs also absorb near-infrared (NIR) 
light, generating heat.9 These unique properties facilitate 
the use of CNTs in drug delivery and thermal treatment of 
cancer.9
QDs are semiconductor nanocrystals with superior 
fluorescent properties with less photobleaching compared with 
conventional chromophores.6 The main application for QDs is 
for imaging cancer cells,7 while CNTs have the ability to destroy 
cancer cells via thermal ablation and can function as a tool for 
drug-delivery platforms.8 There has been a great interest in the 
mechanism of cellular uptake of CNTs and different methods 
have been investigated to elucidate this concept. Labeling CNTs 
with fluorescence materials such as QDs enables researchers 
to track the movement of CNTs. The aim of this review is to 
consider the biomedical applications of conjugated CNTs with 
QDs for the diagnosis and treatment of cancer.
Quantum dots
QDs are semiconductor inorganic nanomaterials ranging 
from 1–10 nm. They contain elements found in groups II–IV 
(eg, CdSe, CdTe, CdS, and ZnSe) or III–V (eg, InP and InAs) 
of the periodic table.10 Considerable interest has been shown 
toward these materials in recent years, especially in view of 
their potential applications in biology and medicine.4
A compelling aspect of QDs is their dimensional 
similarities with biological macromolecules, eg, nucleic 
acids and proteins.11 QDs have fluorescent properties which 
offer superior features to conventional organic dyes including 
high quantum yield,12 broad absorption, and narrow emission 
spectra (Figure 1). The properties of these materials include 
the photostability of coated QDs against photobleaching 
and tolerance to changes in the pH of biological electrolytes 
when compared to fluorescent organic molecules.13 QDs can 
be engineered allowing particle size, shape, and chemical 
composition to be modulated to suit a given application. 
Two properties that are often manipulated are the size and 
composition of QDs; this will determine whether the QD 
is chemically excited in ultraviolet (UV) or NIR light. For 
example, nanocrystals of 2-nm size, comprising CdSe, emit light 
in the range 495–515 nm, whereas larger CdSe nanocrystals 
of 5-nm size emit light in the range 605–630 nm.
As mentioned earlier, one of the important features of 
QDs is that they are more photostable than conventional 
fluorophores, eg, it has been reported that, under the 
same excitation conditions, 90% of the fluorescence of a 
normal organic dye fades within 1 minute, whereas the 
fluorescence of QDs remains intact even after 30 minutes,14 
a further feature of these materials is that they may be 
excited repeatedly.4 When both QDs and rhodamine green–
dextran were exposed to 450 nm light for 80 minutes, the 
fluorescence of rhodamine–dextran was lost whilst QDs 
remained fluorescently stable.15 In addition, QDs have a wide 
excitation spectra and narrow emission spectra compared 
with conventional dyes. These properties of QDs renders 
these materials well suited for multiplex imaging.16
In terms of the biological application of QDs, promising 
data have been obtained regarding the toxicity of these 
Figure 1 QDs synthesis in our laboratory. 
Abbreviation: QDs, quantum dots.
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materials in their surrounding environment. When 108 QDs 
were injected into zebra fish embryos there was no observed 
effect on the embryogenesis.17 QDs conjugated to tumor cells 
have been used to study the extravasion step in the metastatic 
process. In this approach, tumor cells with QDs attached as 
well as native tumor cells were observed to extravaste into 
the surrounding tissue in a comparable manner, showing the 
utility of QDs for monitoring this complex process.14,18
Structural design of QDs
QDs consist of an inorganic core, an inorganic shell and 
aqueous organic coating. The size of the inorganic core 
determines the wavelength (color) of light emitted following 
excitation. An inorganic core consisting of group III–V 
elements is preferable for clinical work in comparison to 
group II–IV elements. This is mainly due to the higher 
stability and lower toxicity of the group III–V elements. 
Different results by various research groups have indicated 
that cadmium (in group III–V) is extremely toxic if allowed 
to leach into the environment and this material also has 
DNA-damaging properties. Other studies have shown that 
using cadmium in the cellular environment may lead to 
the formation of reactive oxygen species, resulting in cell 
death.19 The stability of groups III–V is known to be due to 
the presence of covalent rather than ionic bonding,20 but one 
of the main disadvantages of group III–V is its low quantum 
yield in comparison to group II–VI.21
The inorganic shell is responsible for increasing the 
photostability and luminescent properties of the QDs and 
the aqueous organic coating is used for conjugation of 
biomolecules to the QD surface22 (Figure 2). The photo 
stability of the inorganic shell has allowed QDs to be used 
as probes for imaging cells and tissues over long time 
periods: a challenging task that necessitates collection of 
multiple optical sections without damage to the specimen 
or the aqueous organic coating to which biomolecules are 
conjugated.
Bimolecular coatings such as the attachment of antibodies 
enable the delivery of QDs to a specific organ or another site 
of action. The choice of antibody is important as antibody size 
may increase the overall size of the quantum dot to between 
5–30 nm23 (Figure 3). QDs have been shown to accumulate 
at disease sites and appear as bright and easily distinguish-
able stains after illumination, which allows the location of 
diseased tissue to be identified.15,20
While there are many useful features of QDs, a number 
of issues related to their structure and function still need to 
be resolved. One of the most problematical is a phenomenon 
known as “blinking”. This is the term used to describe the 
alternation between the light-emitting and -nonemitting state 
of the QD. This factor limits the number of photons that can 
be detected in a given time period and it also contributes 
to unpredictable photon arrival times. This issue imposes 
some limitations to the application of QDs and is not fully 
understood. It has been proposed that this feature of QDs 
might be suppressed by “passivating” the QDs’ surface with 
thiol moieties, or by using the QDs in free suspension.21 
Improvement of solubility, stability, and especially the 
toxicity of the QDs in various environments has also received 
considerable interest in recent years.19 Various groups have 
shown that factors including size, capping materials, dose, 
surface chemistry, and coating have direct influence on the 
above issues, eg, the use of zinc sulfide (ZnS) in the inorganic 





Figure 2 Schematic diagram of QD structure; QDs consist of an inorganic core, an 
inorganic shell, and aqueous organic coating. 







Figure 3 Schematic diagram showing the interaction between CD3 receptors on 
the Jurkat T leukemia cell membranes and a CNT-QD nanoassembly. 
Note: A biotinylated anti-CD3 monoclonal antibody was used to link CD3 to the 
nanoassembly.
Abbreviations: CNT, carbon nanotube; QDs, quantum dots.
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such as polyhedral oligomeric silsesquioxane–polycarbonate 
urethane (POSS-PCU) or polyethylene glycol (PEG)24 has also 
been suggested as a method for further improvement of the 
solubility of QDs.18,19
Carbon nanotubes
CNTs comprise well-ordered carbon atoms with a high aspect 
ratio, high surface area, ultralight weight, high loading capacity, 
and high chemical and thermal stability. The synthesis of CNTs 
can be achieved using several methods including electric 
arc discharge, laser ablation or catalytic decomposition of 
hydrocarbons, with each method producing CNTs having 
differing properties. Nevertheless, these materials have unique 
structural, electronic, mechanical, and optical properties and 
potential for application in many fields.25,26 More recently, 
interest in this area has been sparked by the potential for 
using CNTs as drug-delivery systems for cancer treatment.27 
In addition, the passive accumulation of CNTs at tumor sites 
through an enhanced permeability and retention (EPR) effect 
appears to be a tumor-specific property.25
CNTs are available as single-walled (SWCNT) and as 
multiwalled structures (MWCNT). SWCNTs consist of a 
single cylindrical carbon layer with a diameter of 0.2 to 2 nm;28 
SWCNTs have a high ratio of length over diameter (aspect 
ratio) whilst MWCNTs are formed by several concentric 
layers of rolled graphite with an inner diameter of 1 to 3 nm 
and an outer diameter of 2 to 100 nm.29 MWCNTs offer 
greater potential for drug delivery due to their wider inner 
diameter in comparison to SWCNTs allowing greater drug 
loading. It has also been suggested that the outer shell of 
MWCNTs can be functionalized without damage to the side 
walls.30 There are two main approaches for attachment of 
drugs to the surface of MWCNTs: covalent and noncovalent 
attachment; by this process drugs can be incorporated into 
the interior of the CNT.31 In addition to the drug-loading 
properties of MWCNTs, the chemical and mechanical stability 
of MWCNTs enables transport of drugs in a range of diverse 
environments. MWCNTs release substantial vibrational energy 
after exposure to NIR light resulting in localized heating. This 
feature of MWCNTs offers potential as an approach to tumor 
therapy.30
In summary, CNTs offer the potential for drug delivery and 
thermal treatment of tumors whilst QDs offer the potential for 
tumor imaging. Taken together, these nanomaterial properties 
offer the opportunity for a compound to be engineered 
to enable the simultaneous diagnosis and treatment of 
cancer.7
Conjugating CNTs to QDs
CNTs have a large chemically active surface area; a feature 
which offers the support of semiconductor nanoparticles, 
eg, QDs.32 The QDs may be linked to the CNT surface by 
either direct attachment or an intermediate molecule such as 
a polymer that has previously been conjugated to either the 
CNT or the QD. Regardless of the approach used, the bonds 
linking the two nanostructures will be either covalent33 or 
noncovalent.26 The conjugation of nanomaterials to the CNT 
via covalent bonding may be achieved using acid solutions 
that functionalize the surface of these materials to provide 
a suitable platform for the CNTs to form covalent bonds 
with, eg, QDs. An issue with this approach, however, is 
that the oxidation of the CNTs may be nonuniform, leading 
to uneven coverage of the surface and in this scenario 
the nanoparticles tend to attach towards the ends of the 
CNTs corresponding to the topographical distribution of 
the functional groups.25 In comparison, the noncovalent 
approach mitigates this concern.34 In covalent bonding, 
a linker between the functional group of the CNTs and QDs 
is needed. For example, 1-ethyl-3-(3-dimethylaminopropyl) 
carbodiimide hydrochloride (EDC) may be employed; this 
simply sticks to the surface allowing weak intermolecular 
interactions between the CNT and the QDs.35 Figure 4 shows 
QDs coupled covalently to amine and silica functionalized 
MWCNTs.36 Whilst direct coupling is a means of conjugating 
CNTs to QDs, it may be the case that this type of coupling 
results in quenching of the fluorescence of the QD, and this 
in turn may result in reduced ability to visualize the QDs.7 
Another potential issue is partial coverage of the CNTs with 
QDs. Prefunctionalization of the surface of the CNTs with 
a polymer-wrapping technique may prove helpful. In this 
approach, the QDs form bonds with a polymer that coats the 
CNT side wall. Such a method may also prevent the CNT 
side wall from invasive damage and defects and also ensures 
stability of the QDs on the CNT. Various polymers have been 
used for conjugation of the QDs to CNTs (Table 1). Sodium 
dodecyl benzene sulfonate (SDBS) has been used as a linker 
for the conjugation of QDs (in this case ZnO) to CNTs in 
a polar solvent. In this approach the SDBS is prepared in 
ethanol, forming a micelle, the core of which is hydrophobic 
(Figure 5).37
Another approach is to link 1-pyrene butyric acid 
N-hydroxysuccinimide esters (PBASE) to the CNTs through 
π–π interactions. The QDs form noncovalent bonds to the 
CNTs coated with PBASE.34 A similar experiment was 
performed using polyethylene imine (PEI) to load the QDs 
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onto the surface of CNTs. The high aspect ratio and the 
“proton-sponge” effect of CNT-PEI, provides a platform for 
loading QDs onto the surface of CNT-PEI.38 Streptavidin, 
which has a molecular weight of 64 kDa, has been used to 
conjugate QDs to CNTs. The resulting complex was fully 
dispersed in phosphate-buffered saline; in contrast to the 
hydrophobic nature of pristine CNTs, these supramolecular 
nano assemblies were visible by conventional fluorescence 
microscopy and appear as individual tubes or small 
rope-like aggregates when viewed by transmission electron 
microscopy.7
Another novel possibility is to functionalize CNTs with 
nanocomposite polymers,39 for instance, POSS-PCU,40 
increasing the dispersion of CNTs in biological systems41 due 
to its amphiphilic nature.42 POSS-PCU is a thermoplastic that 
is resistant to degradation43 and has anticalcification effects;44 
it demonstrates superior biocompatibility and is currently 
being assessed for use in medical implants.45 POSS-PCU 
may be noncovalently bonded to CNTs via π–π  interactions 
of the aromatic rings of the urea hard segment, which bears 
stark similarities to the bioconjugation of doxorubicin 
to CNTs.46 The POSS-PCU on the surface of the CNT may 
then act as a platform for noncovalent conjugation and load-
ing of QDs.22 Here at the Department of Nanotechnology and 
Regenerative Medicine at the University College, London, 
octa-ammonium-POSS was used as a tool for coating the 
surface of CNTs. In this experiment, the ammonium group 
of the octa-ammonium-POSS was initially converted to the 
amine group by reacting it with NaOH. Conversion of the 
ammonium groups on the POSS molecule into amine groups 
allowed for eight functional groups suitable for linkage to 
the carboxylic acid group (-COOH) on functionalized QDs. 
Following the treatment of octa-ammonium-POSS with 
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Figure 4 Schematic diagram, showing the conjugation of both QDs to CNT and QDs to CNT coated with SiO2. 
Abbreviations: CNT, carbon nanotube; QDs, quantum dots.
Table 1 Example of the materials used for the attachment of CNT to QDs
Type of CNT Type of QDs Material used for  
conjugation
 Final products
MWCNT37 CdTe PEI MWCNT-PEI-CdTe
MWCNT36 CdSe SiO2 MWCNT-SiO2-CdSe
SWCNT34 CdSe PBASE SWCNT-PBASE-CdSe
SWCNT7 CdSe Str SWCNT-Str-CdSe
MWCNT37 CdSe SDBS MWCNT-SDBS-CdSe
MWCNT35 CdSe Mercaptoacetic acid MWCNT-CdSe
Abbreviations: MWCNT, multiwalled carbon nanotubes; SWCNT, single-walled carbon nanotubes; Cdse, cadmium selenide; CdTe, cadmium telluride; PEI, polyethylene 
imine; SiO2, silica; PBASE, 1-pyrene butyric acid N-hydroxysuccinimide ester; QDs, quantum dots; Str, streptavidin; SDBS, sodium dodecyl benzene sulfonate.
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This improved the dispersibility and the biocompatibility of 
the CNT. In addition, a platform for the uniform attachment 
of the QDs-COOH on the CNT’s surface was formed. Our 
finding showed that the attachment of the QDs to the CNT 
generated a more intense fluorescence emission spectra in 
comparison to the direct attachment approach.
Factors that influence conjugation 
of CNTs with QDs
The size of CNT is an important factor that determines the 
location of attachment of QDs to the CNT. When CNTs 







for extended periods of time, the majority of CNTs exhibit 
reduced segment size. Also, it has been suggested that for 
very short nanotubes, the likelihood of sidewall attachment 
of QDs as opposed to end-binding of QDs is reduced. As the 
size of the CNT decreases, so the number of QDs that tend 
to form bonds at the end of the CNT increases. For the QD 
to attach to the end of the CNT, the tubes need to be roughly 
200 nm long ensuring that no acid group is attached to the side 
walls. Conjugation of the QD to the CNTs may be achieved 
in three different ways: (i) via QD clustering at one end of 
a CNT; (ii) via QD clustering at both ends of a CNT; and 
(iii) via a QD cluster “sandwich” between two CNTs.
The distance between the QD and the CNT influences 
quenching of the QD;32 the closer the QD to the CNT, the less 
QD fluorescence. QD size also influences the quenching of 
QDs; smaller QDs have a higher surface-to-volume ratio and 
therefore for smaller QDs, the quenching is increased. The 
concentration of the CNTs plays a role in the luminescent 
intensity of QDs; a gradual decrease in photoluminescent 
intensity of QD-CNT conjugates has been reported when the 
CNT concentration increases from 50 to 200 mg/L.37 Once 
QDs are attached to CNTs, the energy transfer between the 
conjugated species and the CNT occurs in the photoexcited 
state. In the excited state, the electrons from the donor are 
transferred to the acceptor via channels through long-range 
dipole–dipole interactions; this results in the attenuation of 
the photoluminescent emission of the QDs.37 The factors that 
could influence transfer of electrons, are spectral overlap 
integral, center-to-center distance and relative orientation 
of donor and acceptor.32
Methods for characterization  
of CNT-QDs complex
The most commonly used methods to verify the conjugation of 
QDs to CNTs are atomic force microscopy and transmission 
electronic microscopy25 (Figure 6). Another method that 
Figure 6 Transmission electron micrographs (TEM) illustrating (A) MWCNT-NH2; 
(B) 2.8–4.6 nm CdSe QDs; (C) mixture of MWCNT-COCl and QDs-COOH; 
(D) QDs/MWCNT = 1:10; (E) QDs/MWCNT = 1:1; (F) QDs/MWCNT = 10:1; 
(G) high-resolution TEM image of QDs-MWCNT (QDs/MWCNT = 1:1).
Note: Copyright © 2006. Reprinted with permission from Elsevier. Pan B, Cui D, 
He R, Gao F, Zhang Y. Covalent attachment of quantum dot on carbon nanotubes. 
Chem Phys Lett. 2006;417(4–6):419–424.35














Figure 5 Formation of ZnO QD–MWCNT composites. 
Note: Sodium dodecyl benzene sulfonate (SDBS) was used as a linker for conjugation 
of QDs (in this case ZnO) to CNTs in a polar solvent. 
Abbreviations: CNTs, carbon nanotubes; MWCNT, multiwalled carbon nanotubes; 
QDs, quantum dots.
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could be used to confirm the attachment of CNTs to QDs is 
Fourier transform-infrared (FTIR).37
In an experiment, the FTIR technique was used to investigate 
the attachment of QDs to CNTs. Oxidized MWCNTs give 
spectral peaks at 1644 cm-1, 1704 cm-1, and 3403 cm-1, which 
is consistent with the characteristic peaks of carboxylic acid 
and phenolic groups on acid treatment of MWCNTs. However 
once MWCNTs are conjugated to QDs, new peaks appear 
at 1653 cm-1, 2977 cm-1, and 3411 cm-1; these correspond 
to C=O-, C-H-, and N-H-stretching modes of amide and 
may be used to determine the formation of MWCNT-QDs 
conjugated through amide bonds.47
Another method used to investigate structural and 
electronic change following coupling of QDs to CNTs was 
Raman spectroscopy.37 UV-VIS spectroscopy may also be 
used to check the stability of QD-CNT conjugates in aqueous 
solutions. Using this approach, QD-CNT conjugates have 
been observed to be stable for up to 7 weeks.35
The effect of concentration of QDs 
on conjugation to CNTs
Increasing the concentration of QDs affects their spatial 
arrangement on the surface of the CNTs. When the 
quantity of QDs to be linked to SWCNTs is increased 
so they become more uniformly distributed across the 
entire surface (15, 25, and 50 µM) and this is associated 
with a reduction in aggregate formation, however, the 
QD loading must be determined for each experimental 
condition.37
Conjugation of CNTs to QDs  
and the effect on the UV-VIS 
absorption spectra
The absorption spectrum of pure MWCNTs and those coated 
with SiO
2
 are similar in that they are featureless, with a higher 
degree of scattering in the MWCNTs coated with SiO
2
. When 
the CNTs are attached to QDs minor changes to the spectra 
are observed, however, upon the conjugation of QDs to CNT, 
precoated with silica, the composites retain their luminescence 
spectra with intense absorption peaks observed.36
Biomedical applications of CNTs 
conjugated to QDs
The QD-CNT complex has applications in engineering 
through to biomedical sciences. Massive developments have 
been taking place in the usage of QD-CNT complexes in the 
optoelectronic and biosensor fields.48 The recent industrial 
usage of QD-CNT complexes includes the areas of computer 
science, electronics, and mechanical engineering.49
The conjugation of QDs to CNT can result in novel 
hybrid nanocomposite materials displaying unique physical 
and biological properties.50 Due to the electrochemical 
luminescent properties of QD-CNT complexes,51 one of 
the major applications of these materials is intracellular 
fluorescent imaging.22 Furthermore, QD-CNT complexes 
can also function as biosensors and biological nanoprobes 
as well as tools for drug delivery into cells.52
In terms of their application as nanoprobes, one of the 
main advantages of these materials in comparison to organic 
fluorophores is their ability to be observed with high-
resolution electron microscopy.53 In contrast to spherical 
nanoparticles, longer nanotubes have a larger inner volume, 
which allows the CNT to be filled with anticancer drugs,54 
potentially enabling CNTs to deliver anticancer drugs to a 
given site. However in order to target the drug-loaded CNTs 
to the site of action, the surface of these materials need to be 
modified, preferably with the use of an antibody or a peptide 
(eg, anti-HER2 of the tubes to cancer cells). For example, 
since the number of folic acid receptors on the surface of 
the cancer cells increases, the presence of folic acid on CNT 
allows the tubes to be used to target cancer cells and enhance 
drug delivery.55 CNTs loaded with the anticancer drugs are 
injected into the circulation so that the antibody on the surface 
of the CNTs would direct these materials to the site of action.56 
The drugs contained within the CNT are delivered to the cells 
depending on stimulation factors such as a change in the pH or 
by an enzyme produced by the tumor that may cleave the drug 
molecule and release them from the nanotube. Identifying the 
location of CNTs pre- and postdrug delivery is currently the 
main aim of researchers working in this area. Combining QDs 
to CNTs may enable the CNT to be located to particular cell 
types and has been shown not to be a barrier to penetration into 
inaccessible tumor sites. In addition, the QD-CNT complex is 
less likely to be recognized by macrophages and minimizing 
engulfment would prolong the blood circulation, enhancing 
the drug-delivery process. In addition, it has recently been 
shown that QD-CNT complexes conjugated to drugs does 
not affect their pharmacological properties.10 By attaching 
different QDs to CNTs containing different drugs, the delivery 
of drugs to cancer cells could be monitored, which allows 
the efficacy of treatments to be evaluated.57 Although there 
have been many suggestions with regards to the conjugation 
of QDs to CNTs and their application in the area of drug 
delivery there is limited understanding of the limitations of 
this approach. The attachment of QDs to the surface of CNTs 
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limits spaces for the attachment of the anticancer drugs to 
the CNT surface.54
Limitations of CNTs conjugated  
to QDs in vivo
Once a large particle enters the vasculature, it is likely to be 
removed through the reticuloendothelial system, however, 
if the size of the particles is small enough ie, on a nanoscale 
(,100 nm) they would bypass this process. When CNTs are 
coated with QDs, their diameter exceeds 200 nm, which renders 
them potentially immunogenic and likely to be transported for 
destruction in the liver or spleen. In order to overcome this 
problem, SWCNTs have been used in place of MWCNTs. 
SWCNTs have a diameter in the range of 1 to 3 nm whereas 
the diameter of the MWCNT are in the range of 70 to 150 nm. 
Smaller QDs may also be synthesized thereby reducing the 
final diameter of the construct.8 Another major problem is 
attenuation of the photoluminescent properties of QDs: upon 
conjugation to CNTs, the photoluminescence of QDs-MWCNT 
has been reported to be decreased by 50% in comparison to the 
photoluminescence of QDs alone.34 Increasing the concentration 
of functionalized CNT results in increased quenching of QDs, 
the effect is most prominent for CNT-NH
2
, less pronounced 
for CNT-OH, and weakest for CNT-COOH. Despite the above 
findings, a recent study showed minimum changes to the 
quenching of QDs upon conjugation to MWCNT.58
Directing nanoparticles  
to cancer cells
Research is ongoing in an attempt to understand the important 
factors and to establish systems for successful uptake of 
nanoparticles into cancer cells.10 The entry of nanomaterials 
into the cell requires transit across the nanometer-thin lipid 
bilayer. This may occur through a range of mechanisms, 
eg, via endocytosis or receptor-mediated uptake, which are 
also known as active or passive transport mechanism. The 
latter would rely on adequate surface functionalization and 
passive targeting is much slower and less efficient than active 
targeting. When passive targeting is used, QDs accumulate 
in tumor cells due to their enhanced membrane permeability 
and the retention effect. For nanomaterials to be useful in a 
clinical setting, they must demonstrate the following basic 
requirements: (1) minimal aggregation during long-term 
storage; (2) water solubility; (3) retain their functionality; 
and (4) be biocompatible with respect to the target.
Conclusion and future directions
The emergence of nanotechnology in biology and medicine 
has garnered significant attention and interest in recent years. 
The novel properties of CNTs and QDs make them particularly 
attractive candidates in experimental nanobiology. The 
progression from the laboratory bench to clinical bedside 
largely depends on elucidating the mechanism of action 
of these nanoparticles and its interaction with the human 
immune system. Nevertheless, the potential for CNTs and 
QDs to function as multimodal nanotheranostic agents would 
likely pave the way for future treatment designs. Using CNTs 
conjugated with QDs has opened doors to a new generation 
of scientific research that has the potential to revolutionize 
the future of medicine.
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